Seoul National University Hospital: Pancreatic Neoplasms trials
The registry lists 22 Pancreatic Neoplasms studies with Seoul National University Hospital as lead sponsor. 3 are open to participants now and 1 have results posted.
Phase 1 2Phase 2 6Phase 3 3Phase 4 2No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)RecruitingNCT05529940Phase 3
- NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic CancerRecruitingNCT04371224Phase 2
- Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled TrialRecruitingNCT03957135Not applicable
- Standardization of Surgery on the Pancreatic CancerCompletedNCT00679913Phase 3Results posted
- An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic CancerCompletedNCT06129812
- DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic CancerStatus unknownNCT05604573
- Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic CancerStatus unknownNCT05262452Not applicable
- Pancreas Cancer Surveillance Using an Abbreviated MRIActive, not recruitingNCT04592393Not applicable
- Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic CancerActive, not recruitingNCT04447092Phase 2
- The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic CancerStatus unknownNCT03401827Phase 4
- Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent UndersamplingStatus unknownNCT02944006
- Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic CancerCompletedNCT02894944Phase 1
- Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer PatientsStatus unknownNCT02862015Phase 2
- Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 ImmunostainingCompletedNCT02486497Not applicable
- Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic CancerCompletedNCT02190071
- Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer PatientsCompletedNCT02150135Phase 1
- Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug.Status unknownNCT01922492Not applicable
- Role of Perfusion CT in Pancreatic CancerStatus unknownNCT01703650
- Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic CancerCompletedNCT01458717Phase 2/3
- Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic CancerCompletedNCT01396681Phase 2
- Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic CancerCompletedNCT01396668Phase 2
- Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas CancerStatus unknownNCT01111591Phase 4